Since mutations in the MECP2 gene were first reported in 1999 in female and male patients with Rett syndrome (RTT) (OMIM #312750) [14,15], genetic alterations ranging from single nucleotide mutations to large deletions have been described and associated with RTT. This evidence concerns the gene MECP2 and atypical Rett syndrome.